Methodological quality assessment should move beyond design specificity

被引:1
|
作者
Stone, Jennifer C. [1 ,2 ]
Glass, Kathryn [3 ]
Ritskes-Hoitinga, Merel [4 ,5 ]
Munn, Zachary [2 ]
Tugwell, Peter [6 ]
Doi, Suhail A. R. [7 ]
机构
[1] Australian Natl Univ, Res Sch Populat Hlth, Dept Hlth Serv Res & Policy, Canberra, ACT, Australia
[2] Univ Adelaide, Fac Hlth & Med Sci, JBI, Adelaide, SA, Australia
[3] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia
[4] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, SYRCLE, Nijmegen, Netherlands
[5] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[6] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[7] Qatar Univ, Coll Med, Dept Populat Med, Doha, Qatar
基金
澳大利亚国家健康与医学研究理事会;
关键词
bias; critical appraisal; meta-analysis; methodology; quality; RANDOMIZED CONTROLLED-TRIALS; BIAS; SCALES;
D O I
10.11124/JBIES-22-00362
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective:This study aimed to assess the utility of a unified tool (MASTER) for bias assessment against design-specific tools in terms of content and coverage. Methods:Each of the safeguards in the design-specific tools was compared and matched to safeguards in the unified MASTER scale. The design-specific tools were the JBI, Scottish Intercollegiate Guidelines Network (SIGN), and the Newcastle-Ottawa Scale (NOS) tools for analytic study designs. Duplicates, safeguards that could not be mapped to the MASTER scale, and items not applicable as safeguards against bias were flagged and described. Results:Many safeguards across the JBI, SIGN, and NOS tools were common, with a minimum of 10 to a maximum of 23 unique safeguards across various tools. These 3 design-specific toolsets were missing 14 to 26 safeguards from the MASTER scale. The MASTER scale had complete coverage of safeguards within the 3 toolsets for analytic designs. Conclusions:The MASTER scale provides a unified framework for bias assessment of analytic study designs, has good coverage, avoids duplication, has less redundancy, and is more convenient when used for methodological quality assessment in evidence synthesis. It also allows assessment across designs that cannot be done using a design-specific tool.
引用
收藏
页码:507 / 519
页数:13
相关论文
共 50 条
  • [1] Should We Move Beyond Mean Heart Dose?
    Loap, Pierre
    Fourquet, Alain
    Kirova, Youlia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (02): : 386 - 387
  • [2] Generalizability and Disciplinary Specificity of Quality Criteria. Reply to the Commentary "Beyond the Methodological Divide: A Commentary on 'Quality Criteria in Sociology'"
    Otte, Gunnar
    Sawert, Tim
    Bruederl, Josef
    Kley, Stefanie
    Kroneberg, Clemens
    Rohlfing, Ingo
    ZEITSCHRIFT FUR SOZIOLOGIE, 2024, 53 (01): : 97 - 104
  • [3] How to move beyond quality improvement projects
    Shah, Amar
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [4] When Should You Move Beyond First-Line Therapy for Depression?
    McIntyre, Roger S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 : 16 - 20
  • [5] Fiber Tracking-We Should Move Beyond Diffusion Tensor Imaging
    Nimsky, Christopher
    WORLD NEUROSURGERY, 2014, 82 (1-2) : 35 - 36
  • [6] Beyond the Methodological Divide: A Commentary on "Quality Criteria in Sociology"
    Erhard, Franz
    Schaefer, Robert
    ZEITSCHRIFT FUR SOZIOLOGIE, 2024, 53 (01): : 89 - 96
  • [7] What is the quality in your quantity? Library development assessment should look beyond mere numbers
    Jennings, Karlene Noel
    BOTTOM LINE, 2007, 20 (03): : 125 - 127
  • [8] Risk of bias assessment should not go beyond reporting assessment
    Faggion, Clovis Mariano, Jr.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 72 : 126 - 127
  • [9] Beyond Frailty in Alzheimer’s Disease: Should We Move to the Concept of Intrinsic Capacity?
    Antoine Garnier-Crussard
    V. Dauphinot
    A. Zamudio-Rodriguez
    P. Krolak-Salmon
    The Journal of Prevention of Alzheimer's Disease, 2022, 9 : 813 - 815
  • [10] Why we should move beyond the 23 Gray limit for kidney absorbed dose
    Brosch-Lenz, Julia
    Saboury, Babak
    Rahmim, Arman
    Uribe, Carlos
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64